AXL receptor tyrosine kinase: a possible therapeutic target in acute promyelocytic leukemia

Overview of attention for article published in BMC Cancer, June 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 10 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 77,993 followers.

-Publication of my MS research featured on @BioMedCentral official page.

25 Jun 2021

Reply Repost Favourite

Research published in #BMCCancer explores the role of AXL receptor tyrosine kinase as a potential therapeutic target in acute promyelocytic leukemia, a type of blood cancer, and its role in developing resistance to current therapeutics. https://t.co/V0mtef

25 Jun 2021

Reply Repost Favourite

AXL receptor tyrosine kinase: a possible therapeutic target in acute promyelocytic leukemia https://t.co/RyzVovBYaI

18 Jun 2021

Reply Repost Favourite

New article: AXL receptor tyrosine kinase: a possible therapeutic target in acute promyelocytic leukemia https://t.co/g2zzdwc3Uh #AML #leusm #hematology https://t.co/6nFpk6G6uU

18 Jun 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.